Sangamo Therapeutics Inc (SGMO) valuation · rev $39.6M
Sangamo Therapeutics Inc (SGMO) rev $39.6M.
| Metric | Value |
|---|---|
| Market cap | $74.6M |
| Revenue | $39.6M |
| P/S | 1.9 |
| P/B | 18.1 |
SGMO valuation FAQ
What is SGMO's market cap?
Sangamo Therapeutics Inc (SGMO) market cap is $74.6M on the latest cached fundamentals snapshot.
What is SGMO's latest revenue?
Latest cached Sangamo Therapeutics Inc (SGMO) revenue was $39.6M. Statements: https://lician.com/financials/sgmo
What is SGMO's price-to-sales ratio?
Sangamo Therapeutics Inc (SGMO) price-to-sales (P/S) is 1.9, cached market cap $74.6M divided by revenue $39.6M.
What is SGMO's price-to-book ratio?
Sangamo Therapeutics Inc (SGMO) price-to-book (P/B) is 18.1 on the latest cached fundamentals snapshot.
How many SGMO valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Sangamo Therapeutics Inc (SGMO): Market cap, Revenue, P/S, and P/B.
Where is SGMO valuation listed?
Cached valuation multiples for Sangamo Therapeutics Inc (SGMO) are listed at https://lician.com/valuation/sgmo.
Not investment advice. Cached rows, not a live tape.